Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital

References

• The Cancer Registry of Norway. Cancer in Norway 2001.
   Google Scholar
• Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, . Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104–10.
   PubMed Web of Science ®Google Scholar
• Mala T, Løtveit T. Surgical treatment of oesophageal cancer. Tidsskr Nor Laegeforen 2001;121:2815–7.
   PubMedGoogle Scholar
• Ask A, Albertsson M, Järhult J, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 2003;42:462–75. Review.
   PubMed Web of Science ®Google Scholar
• Koshy M, Esiashvilli N, Landry JC, Thomas CR, Matthews RH. Multiple management modalities in esophageal cancer: Epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist 2004;9:137–46.
   PubMedGoogle Scholar
• Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980;67:381–90.
   PubMed Web of Science ®Google Scholar
• Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus: An effective alternative to surgery. Radiother Oncol 1998;48:15–21.
   PubMedGoogle Scholar
• Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, . Esophageal cancer: Current and emerging therapy modalities. Expert Rev Anticancer Ther 2008;9:1433–48.
   Google Scholar
• Hatlevoll R, Hagen S, Hansen HS, Hultborn R, Jakobsen A, Mäntylä M, . Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study: The second Scandinavian trial in esophageal cancer. Radiother Oncol 1992;24:114–6.
   PubMedGoogle Scholar
• Wobbes T, Baron B, Paillot B, Jacob JH, Haegele P, Gignoux M, . Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 2001;37:470–7.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Ono K, Tsutsui K, Oya N, Okajima K, Hiraoka M, . Esophageal cancer treated with radiotherapy: Impact of total treatment time and fractionation. Int J Radiat Oncol Biol Phys 1994;30:1099–105.
   PubMed Web of Science ®Google Scholar
• Statistics Norway. www.statbank.ssb.no.
   Google Scholar
• Stockeld D, Backman L, Fagerberg J, Granström L. Esophageal cancer in Stockholm county 1978–1995. Acta Oncol 2007;46:1075–84.
   PubMed Web of Science ®Google Scholar
• Leslie MD, Dische S, Saunders MI, Grosch E, Fermont D, Ashford RF, . The role of radiotherapy in carcinoma of the thoracic oesophagus: An audit of the Mount Vernon experience 1980–1989. Clin Oncol (R Coll Radiol) 1992;4:114–8.
   PubMedGoogle Scholar
• Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305–13.
   PubMed Web of Science ®Google Scholar
• Neuhof D, Neumayer F, Einbeck W, Haschemian K, Mai SK, Hochhaus A, . Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer. Acta Oncol 2005;44:168–73.
   PubMed Web of Science ®Google Scholar
• Walsh TN, Noonan N, Hollywood DA, Kelly A, Keeling N, Hennessy TPJ. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462–7.
   PubMed Web of Science ®Google Scholar
• Churn M, Jones B, Myint AS. Radical radiotherapy incorporating a brachytherapy boost for the treatment of carcinoma of the thoracic oesophagus: Results from a cohort of patients and review of the literature. Clin Oncol (R Coll Radiol) 2002;14:117–22.
   PubMedGoogle Scholar
• Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 1991;21:107–14. Review.
   PubMed Web of Science ®Google Scholar
• Shi XH, Yao W, Liu T. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999;51:21–6.
   PubMed Web of Science ®Google Scholar
• Zhao KL, Shi XH, Jiang GL, Wang Y. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 2004;60:123–9.
   PubMedGoogle Scholar
• Wang Y, Shi XH, He SQ, Yao WQ, Wang Y, Guo XM, . Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2002;54:131–6.
   PubMedGoogle Scholar
• Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, . Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593–8.
   PubMed Web of Science ®Google Scholar
• Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Ritsuko K, . INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1151–3.
   PubMedGoogle Scholar
• Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, . Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997;15:277–84.
   PubMed Web of Science ®Google Scholar